A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation
Applied Microbiology and Biotechnology · 09.10.2025 · 109 (1)
DOI: 10.1007/s00253-025-13596-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 09.10.2025. Verfasst von Mansooreh Heravi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Tumor Necrosis Factor-alpha, Receptors, Interleukin-6, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pasteur Institute of Iran.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
- Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. mafakher.l@ajums.ac.ir.
- Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. talebkhan@pasteur.ac.ir.
- Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. nematollahi@pasteur.ac.ir.
- Cell Bank Department, Pasteur Institute of Iran, Tehran, Iran.
- Immunology Department, Pasteur Institute of Iran, Tehran, Iran.
Förderung
- Pasteur Institute of Iran
Zitieren
APA
Heravi, M., Damough, S., Mafakher, L., Talebkhan, Y., Nematollahi, L., Ghazizadeh, L., & Ajdari, S. (2025). A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13596-x
Vancouver
Heravi M, Damough S, Mafakher L, Talebkhan Y, Nematollahi L, Ghazizadeh L, et al. A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13596-x
BibTeX
@article{Heravi2025,
author = {Heravi, Mansooreh and Damough, Shadi and Mafakher, Ladan and Talebkhan, Yeganeh and Nematollahi, Leila and Ghazizadeh, Leila and Ajdari, Soheila},
title = {A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13596-x}
}
EUVIMED